CAPTOPRIL-ASSOCIATED NEUTROPENIA - WHO IS AT RISK

被引：90

作者：

COOPER, RA

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 1983年 / 143卷 / 04期

关键词：

D O I：

10.1001/archinte.143.4.659

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：659 / 660

页数：2

共 10 条

[1]

AMMAN FW, 1980, LANCET, V1, P150

[2] CLOZAPINE-INDUCED AGRANULOCYTOSIS - SITUATION REPORT UP TO AUGUST 1976 [J].

ANDERMAN, B ;

GRIFFITH, RW .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 11 (03) :199-201

[3]

CASE DB, 1981, LANCET, V1, P1362

[4] FATAL PANCYTOPENIA ASSOCIATED WITH THE USE OF CAPTOPRIL [J].

GAVRAS, I ;

GRAFF, LG ;

ROSE, BD ;

MCKENNA, JM ;

BRUNNER, HR ;

GAVRAS, H .

ANNALS OF INTERNAL MEDICINE, 1981, 94 (01) :58-59

[5] TOXIC MANIFESTATIONS OF THIOURACIL THERAPY [J].

MOORE, FD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1946, 130 (06) :315-319

[6]

PISCIOTTA AV, 1973, SEMIN HEMATOL, V10, P279

[7]

STAESSEN J, 1980, LANCET, V1, P926

[8]

VANBRUMMELEN P, 1980, LANCET, V1, P150

[9] CAPTOPRIL-INDUCED AGRANULOCYTOSIS IN SYSTEMIC-SCLEROSIS [J].

WATSON, MA ;

RADFORD, NJ ;

MCGRATH, BP ;

SWINTON, GW ;

AGAR, JWM .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (01) :79-81

[10]

YOUNG GAR, 1980, CLIN HAEMATOL, V9, P483

← 1 →